On Wednesday, Biohaven Ltd. (NYSE: BHVN) reported results from a Phase 2 proof-of-concept study evaluating BHV-7000 for major depressive disorder (MDD). The study did not meet its primary endpoint, a ...

Mark Wiseman has held high-profile roles in law, business consulting and finance, and will lead Canada’s efforts to reboot diplomatic relation with Washington at a critical moment. By Matina ...

It has been declared that Slade are not just for Christmas. Yet, let’s be honest, if there is one band who can still retain credibility over a Christmas song, then they are the ones. Slade – O2 ...

Mark Cuban Cost Plus Drug Co. has added Vegzelma, a biosimilar indicated for six cancer types, to its marketplace for hospitals and other healthcare providers. The company plans to expand its ...